AMGN vs CAC · P/E 24, rev $10.05B vs P/E 11, rev $20.9M
Amgen Inc (AMGN) versus Camden National Corporation (CAC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Camden National Corporation (CAC) is a banks - regional company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CAC revenue for 2026-06-30 was $20.9M. Net income was $44.9M. CAC currently screens at market cap $867.6M and trailing P/E 10.9.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CAC currently screens at market cap $867.6M and trailing P/E 10.9.
Not investment advice. Open the AMGN and CAC stock pages for the full models.
Not investment advice.